ACCENDRA HEALTH INC/VA/ 10-Q

Item 5. Other Information. During the three months ended March 31, 2025, none of our directors or officers informed us of the adoption or termination of a trading plan intended to satisfy Rule 10b5-1(c). Item 6. Exhibits (a) Exhibits 33 Table of Contents ​ ​ ​ ​ ​ ​ ​ ​ ​ 31.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 ​ ​ ​ 31.2 Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 ​ ​ ​ 32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 ​ ​ ​ 32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 ​ ​ ​ 101.INS Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document ​ ​ ​ 101.SCH Inline XBRL Taxonomy Extension Schema Document ​ ​ ​ 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document ​ ​ ​ 101.DEF Inline XBRL Taxonomy Definition Linkbase Document ​ ​ ​ 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document ​ ​ ​ 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document ​ ​ ​ 104 ​ Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101) ​ ​ 34 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ​ ​ ​ Owens & Minor, Inc. ​ (Registrant) ​ ​ Date: May 8, 2025 /s/ Edward A. Pesicka ​ Edward A. Pesicka ​ President, Chief Executive Officer & Director ​ ​ Date: May 8, 2025 /s/ Jonathan A. Leon ​ Jonathan A. Leon ​ Executive Vice President & Chief Financial Officer ​ ​ ​ ​ ​ ​ 35